Why the study?
The study was conducted to compare hemodynamic status and complications between two different doses of intramyometrial vasopressin during laparoscopic myomectomy.
Does 10 units of intramyometrial vasopressin compared to 20 units reduce cardiovascular complications without increasing blood loss in patients undergoing laparoscopic myomectomy?
Does 10 units of intramyometrial vasopressin compared to 20 units reduce cardiovascular complications without increasing blood loss in patients undergoing laparoscopic myomectomy?
Using 10 units of intramyometrial vasopressin instead of 20 units during laparoscopic myomectomy provides similar hemostatic efficacy while reducing cardiovascular complications.
Answers are grounded in this paper and cite their sources.
May support 10-unit dosing to limit cardiovascular effects in myomectomy; hypothesis-generating and requires randomized confirmation before practice change.
Objective: Our aim is comparison of hemodynamic status and complications between two different doses of intramyometrial vasopressin during laparoscopic myomectomy. Methods: We did a retrospective analysis of hemodynamic status and its anesthetic concerns in patients who received two different doses of intramyometrial vasopressin. Eighty patients undergoing laparoscopic myomectomy under general anesthesia were divided into two groups of 40 patients in each group. In Group A (n=40), 10 units of intramyometrial vasopressin in 200 ml of normal saline were given and, in Group B, 20 units of intramyometrial vasopressin in 200 ml of NS were given intraoperatively by surgeon. Results: 20 units intramyometrial vasopressin used dogmatically by surgeons drops blood loss but it is connected with cardiovascular impediments. Hence, 10 units of intramyometrial vasopressin as compared to 20 units which are used by some surgeons are associated with similar blood loss and lesser side effects such as bradycardia, pulmonary edema, hypotension, blood loss, and increased airway pressure. Conclusion: Hence, anesthesiologists and gynecologists must take the precautions to escape and minimize the frequency of impediments with intramyometrial vasopressin by selecting the appropriate dosage of vasopressin.
No takes yet. Share an insight, caveat, or question.
Moda et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: